In a mouse tumor model receiving the in vivo cotransfer of Tregs with CD8+ T cells, NAC1−/− Tregs displayed greater suppressive effect on antitumor immunity than the control Tregs (fig. The gene discussed is CD8A; the disease is neoplasm.